www.neurologiepropraxi.cz / Neurol. praxi. 2024;25(6):455-464 / NEUROLOGIE PRO PRAXI 463 HLAVNÍ TÉMA Manažment pacienta s kognitívnou poruchou po cievnej mozgovej príhode sia Light and Brief Assessment a Pojmenování obrázků a jejich vybavení a vyšetřovací metody v diagnostice kognitivních poruch a demencí. Med. praxi. 2022;19(1):50-57. 7. Bayles MP, Swank AM, eds. [American College of Sports Medicine]. ACSM Guidelines for Exercise Testing and Prescription. Wolters Kluwer. 2018. ISBN 13:978-1-4963-3907-2. 8. Beekly DL, et al. The National Alzheimer's Coordinating Center (NACC) database: the Uniform Data Set. Alzheimer Disease and Associated Disorders. 2007;21(3):249-258. 9. Bernhardt J, Hayward KS, Kwakkel G, et al. Agreed definitions and a shared vision for new standards in stroke recovery research: The stroke recovery and rehabilitation roundtable taskforce. Neurorehabilitation and Neural Repair. 2017;31:793-799. 10. Binder JR, Frost JA, Hammeke TA, e tal. Human brain language areas identified by functional magnetic resonance imaging. J Neurosci. 1997;17(1):353-62. 11. Bucks RS, Ashworth DL, Wilcock GK, Siegfried K. Assessment of activities of daily living in dementia: development of the Bristol Activities of Daily Living Scale. Age Ageing. 1996;25:113-120. 12. Cao Q, et al. The Prevalence of Dementia: A Systematic Review and Meta-Analysis. Journal of Alzheimer's disease: JAD. 2020;73(3):1157-1166. 13. Coen RF, et al. Strengths and Limitations of the MoCA for Assessing Cognitive Functioning: Findings From a Large Representative Sample of Irish Older Adults. Journal of geriatric psychiatry and neurology. 2016;29(1):18-24. 14. Cui L, Hong H, Wang S, et al. Small vessel disease and cognitive reserve oppositely modulate global network redundancy and cognitive function: A study in middle-to-old aged community participants. Hum Brain Mapp. 2024;45(5):e26634. 15. Custodio N, Montesinos R, Lira D, et al. Mixed dementia: A review of the evidence. Dement Neuropsychol. 2017;11(4): 364-370. 16. Davis C, et al. Definition of the Mediterranean Diet; a Literature Review. Nutrients. 2015;7(11):9139-53. 17. Demeyere N. Acute post-stroke screening for a cognitive care pathway. The lancet. Healthy longevity. 2024;5(1):e4-e5. 18. Dhakal A, Bobrin BD. Cognitive Deficits. In: StatPearls. Treasure Island (FL): StatPearls Publishing. 2022. 19. Diagnostické štandardy MZSR. Dostupné na: https:// www.health.gov.sk/Zdroje?/Sources/dokumenty/ SDTP/ standardy/Nove/Psychiatria-Demencia_pri_Alzheimerovej_chorobe.pdf. 20. Dong Y, Ding M, Cui M, et al. Development and validation of a clinical model (DREAM-LDL) for post-stroke cognitive impairment at 6 months. Aging (Albany NY). 202;13(17):21628-21641. 21. Douiri A, et al. Prevalence of poststroke cognitive impairment: South London Stroke Register 1995–2010. Stroke. 2013;44,(1):138-45. 22. Erickson KI, Hillman C, Stillman CM, et al. Physical Activity, Cognition, and Brain Outcomes: A Review of the 2018 Physical Activity Guidelines. 2018 PHYSICAL ACTIVITY GUIDELINES ADVISORY COMMITTEE*. Med Sci Sports Exerc. 2019;51(6):1242-1251. 23. Evans MDR, Kelley P, Kelley J. Identifying the Best Times for Cognitive Functioning Using New Methods: Matching University Times to Undergraduate Chronotypes. Front Hum Neurosci. 2017;11:188. 24. Friedman NP, Robbins TW. The role of prefrontal cortex in cognitive control and executive function. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. 2022;47(1):72-89. 25. García-Alberca JM, Mendoza S, Gris E. Benefits of Treatment with Ginkgo Biloba Extract EGb 761 Alone or Combined with Acetylcholinesterase Inhibitors in Vascular Dementia. Clin Drug Investig. 2022;42(5):391-402. 26. Gauthier L, Gelinas I, Mcintyre M, et al. Disability Assessment for Dementia (DAD) user's guide. 1994. 27. Gauthier S, Gelinas I, Gauthier L. Functional disability in Alzheimer's disease. Int Psychogeriatr. 1997;9(Suppl 1):163-165. 28. GBD 2019 Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021;20(10):795-820. 29. Godefroy O, Yaïche H, Taillia H, et al., and GRECogVASC Study Group. Who should undergo a comprehensive cognitive assessment after a stroke? A cognitive risk score. Neurology. 2018; 91:e1979-87. 30. Heiss WD, Rosenberg GA, Thiel A, et al. Neuroimaging in vascular cognitive impairment: a state-of-the-art review. BMC Med. 2016;14(1):174. 31. Hindmarch I, Lehfeld H, de Jongh P, Erzigkeit H. The Bayer Activities of Daily Living Scale (B-ADL). Dement Geriatr Cogn Disord. 1998;9(Suppl 2):20-26. 32. Chander, Russell J, et al. Development and validation of a risk score (CHANGE) for cognitive impairment after ischemic stroke. Scientific reports. 2017;7(1):12441. 33. Chaves MLF, Godinho CC, Porto CS, et al.; Group Recommendations in Alzheimer’s Disease and Vascular Dementia of the Brazilian Academy of Neurology. Cognitive, functional and behavioral assessment: Alzheimer's disease. Dement Neuropsychol. 2011;5(3):153-166. 34. Chippa V, Roy K. Geriatric Cognitive Decline and Polypharmacy. StatPearls. StatPearls Publishing. 2023. 35. Chiti G, Pantoni L. Use of Montreal Cognitive Assessment in patients with stroke. Stroke. 2014;45(10):3135-40. 36. Iadecola C, Duering M, Hachinski V, et al. Vascular Cognitive Impairment and Dementia: JACC Scientific Expert Panel. J Am Coll Cardiol. 2019;73(25):3326-3344. 37. Jaroenngarmsamer T, Benali F, Fladt J, et al; ESCAPE-NA1 Investigators. Cortical and Subcortical Brain Atrophy Assessment Using Simple Measures on NCCT Compared with MRI in Acute Stroke. AJNR Am J Neuroradiol. 2023. 38. Jokinen H, Kalska H, Mäntylä R, et al. Cognitive profile of subcortical ischaemic vascular disease. J Neurol Neurosurg Psychiatry. 2006;77(1):28-33. 39. Jorm AF, Scott R, Cullen JS, et al. Performance of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) as a screening test for dementia. Psychol Med. 1991;21:785-90. 40. Kalaria RN, Akinyemi R, Ihara M. Stroke injury, cognitive impairment and vascular dementia. Biochim Biophys Acta. 2016;1862:915-925. 41. Kandiah N, Chander RJ, Lin X, et al. Cognitive Impairment after Mild Stroke: Development and Validation of the SIGNAL2 Risk Score. J Alzheimers Dis. 2016;49:1169-77. 42. Kandiah N, Ong PA, Yuda T, et al. Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba extract, EGb 761®. CNS Neurosci Ther. 2019;25(2):288-298. 43. Kaushik S, Vani K, Chumber S, et al. Evaluation of MR Visual Rating Scales in Major Forms of Dementia. J Neurosci Rural Pract. 2021;12(1):16-23. doi: 10.1055/s-0040-1716806. 44. Kim JO, Lee SJ, Pyo JS. Effect of acetylcholinesterase inhibitors on post-stroke cognitive impairment and vascular dementia: a meta-analysis. PLoS One. 2020;15(2):e0227820. 45. Kristensson JH, et al. Medications causing potential cognitive impairment are common in nursing home dementia units – a cross-sectional study. Exploratory research in clinical and social pharmacy. 2021;3:100054. 46. Kwok CS, Loke YK, Hale R, et al. Atrial fibrillation and incidence of dementia: a systematic review and meta-analysis. Neurology. 2011;76:914-922. 47. Lee HB, DeLoatch CJ, Cho S, et al. Detection and management of pre-existing cognitive impairment and associated behavioral symptoms in the Intensive Care Unit. Crit Care Clin. 2008;24(4):723-36. 48. Lee JH, Kim SH, Kim GH, et al. Identification of pure subcortical vascular dementia using 11C-Pittsburgh compound B. Neurology. 2011;77(1):18-25. 49. Li J, Wang J, Wu B, et al. Association Between Early Cognitive Impairment and Midterm Functional Outcomes Among Chinese Acute Ischemic Stroke Patients: A Longitudinal Study. Front Neurol. 2020;11:20. 50. Lim JS, Lee JJ, Woo CW. Post-Stroke Cognitive Impairment: Pathophysiological Insights into Brain Disconnectome from Advanced Neuroimaging Analysis Techniques. J Stroke. 2021;23(3):297-311. 51. Lo EH, Rosenberg GA. The neurovascular unit in health and disease: introduction. Stroke. 2009;40:S2-S3. 52. Lo JW, et al. Profile of and risk factors for poststroke cognitive impairment in diverse ethnoregional groups. Neurology. 2019;93(24):e2257-e2271. 53. Mahoney Fl, Barthel DW Functional evaluation: the Barthel index. Md State Med J. 1965;14:61- 65. 54. Makin SD, Turpin S, Dennis MS, Wardlaw JM. Cognitive impairment after lacunar stroke: systematic review and meta-analysis of incidence, prevalence and comparison with other stroke subtypes. J Neurol Neurosurg Psychiatry. 2013;84(8):893-900. 55. Malleta GJ. The concept of reversible dementia. How nonreliable terminology may impair effective treatment. J Am Geriatr Soc. 1990;38:136-140. 56. Mendonça MD, Alves L, Bugalho P. From Subjective Cognitive Complaints to Dementia Who is at Risk?: A Systematic Review. Am J Alzheimers Dis Other Demen. 2016;31(2):105-114. 57. Nasreddine ZS, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society. 2005;53(4):695-9. 58. Nys GMS, van Zandvoort MJE, de Kort PLM, et al. Cognitive disorders in acute stroke: prevalence and clinical determinants. Cerebrovasc Dis. 2007;23(5-6):408-16. 59. O'Sullivan MJ, et al. Cognitive Recovery After Stroke: Memory. Stroke. 2023;54(1):44-54. 60. Pais R, Ruano LP, Carvalho O, Barros H. Global Cognitive Impairment Prevalence and Incidence in Community Dwelling Older Adults-A Systematic Review. Geriatrics (Basel). 2020;5(4):84. 61. Petersen RC. Mild Cognitive Impairment. Continuum (Minneap Minn). 2016;22(2 Dementia):404-418. 62. Petersen SE, Sporns O. Brain Networks and Cognitive Architectures. Neuron. 2015;88(1):207-19. 63. Powers WJ, et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2019;50(12):e344-e418. 64. Preventívne postupy MZSR. Dostupné na: https://www. standardnepostupy.sk/novy-zoznam-schvalenych-preventivnych-postupov-ppvp/. 65. Quinn TJ, et al. European Stroke Organisation and European Academy of Neurology joint guidelines on post- -stroke cognitive impairment. European journal of neurology. 2021;28(12):3883-3920. 66. Rost NS, Brodtmann A, Pase MP, et al. Post-Stroke Cognitive Impairment and Dementia. Circ Res. 2022;130(8):1252-1271. 67. Sachdev PS, Brodaty H, Valenzuela MJ, et al. Clinical determinants of dementia and mild cognitive impairment following ischaemic stroke: the Sydney Stroke Study. Dement Geriatr Cogn Disord. 2006;21(5-6):275-283. 68. Salvadori E, Cova I, Mele F, et al. Prediction of post-stroke cognitive impairment by Montreal Cognitive Assessment (MoCA) performances in acute stroke: comparison of three normative datasets. Aging Clin Exp Res. 2022;34(8):1855-1863. 69. Salvadori E, Pasi M, Poggesi A, et al. Predictive value of MoCA in the acute phase of stroke on the diagnosis of mid- -term cognitive impairment. J Neurol. 2013;260(9):2220-7. 70. Sexton E, McLoughlin A, Williams DJ, et al. Systematic review and meta-analysis of the prevalence of cognitive impairment no dementia in the first year post-stroke. Eur Stroke J. 2019;4:160-71. 71. Sharma R, Mallick D, Llinas RH, Marsh EB. Early Post-stroke Cognition: In-hospital Predictors and the Association With Functional Outcome. Front Neurol. 2020;11:613607. 72. Schellekens MM, et al. Subacute cognitive impairment after first-ever transient ischemic attack or ischemic stroke in young adults: The ODYSSEY study. European stroke journal. 2023;8(1):283-293.
RkJQdWJsaXNoZXIy NDA4Mjc=